Platelet activating factor (PAF) involvement in endotoxin-induced hypotension in rats. Studies with PAF-receptor antagonist kadsurenone.
暂无分享,去创建一个
Margaret S. Wu | J. C. Robbins | M. Wu | T. Doebber | T. Shen | M. N. Chang | B. Choy | M. Wu | Betty Ma Choy
[1] M. Wu,et al. Platelet activating factor intravenous infusion in rats stimulates vascular lysosomal hydrolase secretion independent of blood neutrophils. , 1984, Biochemical and biophysical research communications.
[2] C. Hinds,et al. Effects of intravascular volume expansion on the cardiovascular response to naloxone in a canine model of severe endotoxin shock , 1984, British journal of pharmacology.
[3] J. C. Ludwig,et al. High performance liquid chromatography of platelet-activating factors. , 1984, Journal of lipid research.
[4] L. McManus,et al. Acetyl glyceryl ether phosphorylcholine (AGEPC). A putative mediator of cardiac anaphylaxis in the guinea pig. , 1984, Circulation research.
[5] F. Snyder,et al. A new class of antihypertensive neutral lipid: 1-alkyl-2-acetyl-sn-glycerols, a precursor of platelet activating factor. , 1984, Biochemical and biophysical research communications.
[6] J. Hildebrandt,et al. Thromboxane A2 mediates lung vasoconstriction but not permeability after endotoxin. , 1983, The Journal of clinical investigation.
[7] R. Bone,et al. Ibuprofen in canine endotoxin shock. , 1982, The Journal of clinical investigation.
[8] J. B. Martin,et al. Endotoxin-stimulated opioid peptide secretion: two secretory pools and feedback control in vivo. , 1982, Science.
[9] W. Zapol,et al. Acute Pulmonary Hypertension and Lung Thromboxane Release after Endotoxin Infusion in Normal and Leukopenic Sheep , 1982, Circulation research.
[10] J. Egido,et al. Vascular actions of synthetic PAF-acether (a synthetic platelet-activating factor) in the rat: evidence for a platelet independent mechanism. , 1982, Immunopharmacology.
[11] W. Mitch,et al. PRESSOR EFFECT OF NALOXONE IN SEPTIC SHOCK , 1981, The Lancet.
[12] R. Farr,et al. Preliminary studies of an acid-labile factor (ALF) in human sera that inactivates platelet-activating factor (PAF). , 1980, Clinical immunology and immunopathology.
[13] F. Snyder,et al. Antihypertensive activity of an alkyl ether analog of phosphatidylcholine. , 1979, Biochemical and biophysical research communications.
[14] D. Hanahan,et al. Physicochemical and functional identity of rabbit platelet-activating factor (PAF) released in vivo during IgE anaphylaxis with PAF released in vitro from IgE sensitized basophils. , 1979, Journal of immunology.
[15] R. Ulevitch,et al. The effects of bacterial endotoxins on host mediation systems. A review. , 1978, The American journal of pathology.
[16] J. Holaday,et al. Naloxone reversal of endotoxin hypotension suggests role of endorphins in shock , 1978, Nature.
[17] M. Laubie,et al. Central cardiovascular effects of morphinomimetic peptides in dogs. , 1977, European journal of pharmacology.
[18] J. Fletcher,et al. MODIFICATION, BY ASPIRIN AND INDOMETHACIN, OF THE HAEMODYNAMIC AND PROSTAGLANDIN RELEASING EFFECTS OF E. coli ENDOTOXIN IN THE DOG , 1977, British journal of pharmacology.
[19] J. Parratt,et al. THE POSSIBLE ROLES OF HISTAMINE, 5‐HYDROXYTRYPTAMINE AND PROSTAGLANDIN F2α AS MEDIATORS OF THE ACUTE PULMONARY EFFECTS OF ENDOTOXIN , 1977, British journal of pharmacology.
[20] W. Jubiz,et al. Endotoxin-induced prostaglandin E and F release in dogs. , 1975, The American journal of physiology.
[21] P. Henson,et al. LEUKOCYTE-DEPENDENT HISTAMINE RELEASE FROM RABBIT PLATELETS THE ROLE OF IGE, BASOPHILS, AND A PLATELET-ACTIVATING FACTOR , 1972 .
[22] W. J. Dyer,et al. A rapid method of total lipid extraction and purification. , 1959, Canadian journal of biochemistry and physiology.